Background
Crestor, a statin drug with high drug-drug interactions, has recently received a major attention in the pharmaceutical industry. It is a statin drug with a high level of lipophilic and hydrophobic drug components that have been detected in the drug matrix and the drugs in the matrix. In the past several years, the presence of lipophilic and hydrophobic drug components in the matrix has been detected in several human blood cells (HBSC) and some pharmaceuticals. This is a common scenario among pharmaceuticals and other bioactive substances. The presence of lipophilic and hydrophobic drug components has been found in various human blood cells (HBSC), including the liver, kidney, and skeletal muscle. Lipophilic drug components are mainly found in the matrix of the HBSC, while hydrophobic and hydrophobic drug components are found in the drug matrix of the HBSC. The presence of lipophilic and hydrophobic drug components has been found in several human blood cells (HBSC), including the liver, kidney, and skeletal muscle. In addition, the presence of hydrophobic and hydrophobic drug components has been found in the drug matrix of HBSC. There are reports in the literature that the presence of hydrophobic and hydrophobic drug components can be detected in human blood cells.
The presence of hydrophobic and hydrophobic drug components is often found in the HBSC and other human blood cells. For example, a study has reported that a human plasma sample from a patient with a hypercholesterolemia showed low levels of hydrophobic and hydrophobic drug components. This indicates that the presence of hydrophobic and hydrophobic drug components is also found in the human blood cells.
In addition to the above, the presence of hydrophobic and hydrophobic drug components is also found in the human blood cells. In this situation, the presence of hydrophobic and hydrophobic drug components is found in the plasma and other body fluids (e.g., blood, urine, stool, etc.), as well as in the plasma samples from patients with chronic diseases. These conditions can cause abnormal hemodynamics and/or the release of substances called lipophilic and hydrophobic substances. Lipophilic and hydrophobic substances are the components of the plasma and other body fluids. The presence of lipophilic and hydrophobic substances in the plasma and other body fluids may be due to the fact that these substances are in the lipid phase of the blood and are bound to plasma proteins. Lipophilic and hydrophobic substances can be produced in a number of ways: by binding to a certain protein (e.g., albumin or calcium carbonate), by binding to a protein that is a part of the plasma protein and/or protein complexes with the plasma proteins (e.g., proteins, albumin, or calcium carbonate), or by binding to the plasma protein and/or protein complexes (e.g., proteins, albumin, or calcium carbonate). In addition, these substances are also produced by other processes, which may lead to the accumulation of lipophilic and hydrophobic substances in the plasma, thus causing the plasma concentration to increase. The increased concentration of lipophilic and hydrophobic substances in the plasma can be caused by the accumulation of the lipophilic and hydrophobic substances. This can be caused by the presence of the lipophilic and hydrophobic substances in the plasma proteins. The accumulation of lipophilic and hydrophobic substances in the plasma can also be caused by the presence of the hydrophobic and hydrophobic substances in the plasma proteins.
It is important to note that the presence of hydrophobic and hydrophobic substances in the plasma is not caused by the presence of the lipophilic and hydrophobic substances in the plasma proteins. It is, however, also possible that these substances are produced in a number of ways: by binding to a protein, by binding to a protein that is a part of the plasma protein, by binding to the plasma protein, or by binding to the plasma protein and/or protein complexes with the plasma proteins.
IntroductionRosuvastatin is an anti-hyperlipidemic agent that is currently being explored as a potential treatment for patients with high cholesterol levels. Rosuvastatin is a synthetic lipid-lowering agent that is metabolized by the cytochrome P450 (CYP) isoforms 3A4 (major route) and 5C8 (minor route) in the liver, and is a potent CYP3A4 inhibitor that reduces LDL cholesterol levels. The goal of this review is to summarize the recent literature regarding the clinical pharmacologic properties of rouvastatin in the treatment of patients with high cholesterol. As an example, we will review the clinical pharmacologic properties of rouvastatin in the treatment of patients with high cholesterol, as well as the pharmacologic effects on LDL cholesterol and triglyceride levels.
AimThe purpose of this review is to summarize the recent literature regarding the clinical pharmacologic properties of rouvastatin in the treatment of patients with high cholesterol.
Material and MethodOur primary aim is to summarize the current literature regarding the clinical pharmacologic properties of rouvastatin in the treatment of patients with high cholesterol, as well as the pharmacologic effects on LDL cholesterol and triglyceride levels.
ResultsWe focused on three main lines of evidence: (1) a randomized placebo-controlled clinical trial (RCT), which compared rouvastatin with a low-salt diet, (2) a clinical trial of rouvastatin and low-salt diet, and (3) a clinical trial of low-salt diet in the treatment of patients with high cholesterol. The results from these studies may be applicable to a variety of clinical settings.
ConclusionsIn clinical pharmacologic studies, rouvastatin is not associated with major adverse cardiovascular events in patients with high cholesterol. However, it may be a potential treatment option for patients with high cholesterol, with the potential for long-term safety and efficacy of rouvastatin, with the ability to reduce LDL cholesterol and triglyceride levels, without significant adverse cardiovascular events. These findings should be discussed with caution in patients with other lipid-lowering agents.
Received:December 17, 2015;Accepted:February 25, 2016;Published:March 22, 2016;DOI:doi: 10.7554/DO:10.7554/CPP-09-1699
Citation:Sallam S, Brouet M, Gao X, Leung X, et al. Rosuvastatin for the treatment of high cholesterol: A randomized, controlled trial. PLoS ONE. 2015;8(5): e106320. https://doi.org/10.1371/journal.pone.0160649
Academic Editor:M. P. Tauler, University of California San Francisco, UNITED STATES
doi:10.7554/DO:10.7554/CPP-09-1699
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The first study that assessed the efficacy and safety of rouvastatin in the treatment of patients with high cholesterol was the RCT of rouvastatin at a low-salt diet (Crestor) or a low-salt diet (Zestrol). The results were consistent with those of a previous study, which showed that rouvastatin significantly reduced LDL cholesterol levels, and that this effect was greater with the Crestor diet than with the Zestrol diet. In addition, in the same RCT, rouvastatin significantly improved the lipid profile of the patients with high cholesterol. A second study that compared rouvastatin to a low-salt diet (Crestor) to reduce the risk of cardiovascular events in patients with high cholesterol was published in the Journal of the American College of Cardiology (JACC), which showed that rouvastatin was associated with a reduction in the risk of coronary heart disease.
Crestor works by reducing a certain enzyme within the body that produces cholesterol. It belongs to a class of medications called statins.
Cholesterol is a form of lipid, a waxy substance that helps your body make cells, vitamins, and certain hormones. It is not inherently bad. Your liver produces an enzyme that synthesizes cholesterol to help with the above healthy functions. Additional cholesterol is introduced to the body through certain foods like meat, poultry, and dairy products.
There are two types of cholesterol: high-density lipoproteins (HDLs) and low-density lipoproteins (LDLs). LDLs carry cholesterol throughout the body, delivering cholesterol to cells that need it. HDLs carry excess LDLs back to the liver, where they are broken down and flushed from the body. While LDLs play a key role in cell health, they build up when the body has more cholesterol than the cells need. This buildup turns into plaque in the arteries (blood vessels). As plaque covers the artery walls, the blood vessels become narrow. This makes it harder for blood to flow through the body, which can lead to heart disease and heart failure.
Statins work by reducing the production of cholesterol in the liver, which lowers the overall cholesterol levels in the body. Not only do statins decrease levels of LDLs in the body, but they can also raise the level of HDLs in the body. In effect, they keep the body from making too much of the “bad” cholesterol that builds up in arteries while increasing the amount of “good” cholesterol that carries the “bad” out of the body. This dual action has been shown, along with diet and exercise, to lower overall cholesterol levels in patients effectively.
Crestor works for youTake your cholesterol with food, particularly when taking high-intensity exercise or taking low-intensity exercise. Establishing proper hydration can help lower total and LDL cholesterol levels in your diet. Drinking enough water and staying adequately tan make the body more efficient at keeping cholesterol levels in check. Following your doctor’s instructions should you feel better before taking your dose. Remember to also keep in mind that while taking CRESTOR may help keep cholesterol levels in check, it does not eliminate it completely. It works in your body to increase the amount of cholesterol carried by your food and other cholesterol-lowering effects.
Taking CRESTOR for longerLong-term CRESTOR use may cause certain side effects, such as muscle weakness, low blood pressure, and headache. These effects should diminish as your body gets used to the CRESTOR dose, leading to improved cholesterol levels and a decrease in LDL cholesterol levels.
Long-term CRESTOR use may not be safe for everyone. Discuss with your doctor if you are pregnant, may become pregnant, or think you may be pregnant. Your doctor/doctor7507 Super Specialty Pharmacy offers generic versions of CRESTOR (rosu-ro CRESTOR). Contact your doctor if your doctor has any questions to refer you to a healthcare provider if you are taking any other medicines, including other brands of CRESTOR.
Do not take CRESTOR if you are currently taking:
CRESTOR can cause side effects in some people. Common side effects may include muscle weakness, weakness, or dizziness. If any of these effects persist or worsen, talk to your doctor right away, and see a doctor later in the day, if needed. In the rare event you experience any of these, stop taking CRESTOR and see your doctor immediately. This may be a sign of a serious side effect.
Do not take CRESTOR if you are also using another lipid-lowering medication. Your doctor/ healthcare provider will discuss with you what other medications are right for you based on your medical history and any existing conditions you have.
Your doctor should discuss with you how long you should use CRESTOR and whether your dose should be increased. Your doctor/doctor7507 Super Specialty Pharmacy offers generic versions of CRESTOR (rosuvastatin CRESTOR).
Long-term CRESTOR use may cause certain side effects, such as muscle weakness, weakness, or headache. These side effects should diminish as your body gets used to the CRESTOR dose, leading to improved cholesterol levels in response to.
Sold and Supplied by Healthylife Pharmacy
This product is a Prescription Only Medicine (S4) and is sold by Healthylife Pharmacy, an independently owned and operated pharmacy business. This prescription product requires a valid Australian script.
Medicare CardNo MedicareConcession
$12.95
Healthylife provides general product information such as nutritional information, country of origin and product packaging for your convenience. This information is intended as a guide only, including because products change from time to time. Please read product labels before consuming. For therapeutic goods, always read the label and follow the directions for use on pack. If you require specific information to assist with your purchasing decision, we recommend that you contact the manufacturer via the contact details on the packaging or email us at [email protected]. Product ratings and reviews are taken from various sources including Bazaarvoice. Healthylife does not represent or warrant the accuracy of any statements, claims or opinions made in product ratings and reviews.
Product(s) contain any inactive ingredientsInactive ingredientsCrestor lowers cholesterol levels, while reducing the risk of heart disease, diabetes, and other conditions.
It's also used to reduce cholesterol in adults with an estimated total cholesterol of less than 10.4 mg/dL (0.6 to 1.2 mmol/L).
Crestor may be prescribed to adults who are overweight or obese with risk factors such as a family history of high cholesterol or diabetes.
You may need to take Crestor regularly for up to three years. It's also prescribed as a statin, which means it lowers cholesterol and can be used to treat high cholesterol. If you are taking Crestor regularly, you should be monitored regularly for signs of hyperlipidemia.
Crestor and other statins are used as replacement therapy to lower cholesterol or to reduce the risk of heart disease. If you have an overactive thyroid, you should not take Crestor.
Read more about Crestor.
You may also see other articles about Crestor.
Crestor may be used to treat anemia, high blood pressure, and high cholesterol.
Stade de France Pharmacy